Menu

Blog

Archive for the ‘bioengineering’ category: Page 128

Nov 26, 2018

RegenerAge — Bioquark — Excélsior TV

Posted by in categories: aging, bioengineering, biotech/medical, business, cryonics, DNA, futurism, genetics, health, transhumanism

Nov 26, 2018

Scientists discover a new route to antibiotics using gene editing

Posted by in categories: bioengineering, biotech/medical

Scientists have discovered a new chemical process—also known as a biosynthetic pathway—in bacteria which could lead to a new generation of antibiotics being produced and manufactured.

Researchers at The University of Manchester’s School of Chemistry say their new pathway includes an , called a carboxylase, which adds CO2 to a precursor molecule producing a highly unusual antibiotic called malonomycin.

The team says the biosynthetic process used to produce this antibiotic could now possibly lead to the discovery and development of other drugs, helping in the fight against drug-resistant bugs and illnesses in the future.

Read more

Nov 26, 2018

Many scientists denounce researcher claiming 1st gene-edited babies born in China

Posted by in categories: bioengineering, biotech/medical, cyborgs, ethics, genetics, law

Not sure if this is real or still vaporware yet. But it IS inevitable. It’s not a matter of “if”, but “when”. And we’re most likely not going to be able to regulate it much, either. If an embryo or fetus is not a human, then parents have the right to do anything they want to it. You might think that this is going to result in eugenics, like erasing melanin genes and starting a race against the fictitious “white genocide”. You’re right. But if you think that’s as bad as it’ll get, think more creatively. What happens when poor parents get paid to implant “willing servility” genes into their unborn children, in order to pay bills. The future is now. Cyborgs will not destroy humanity, but humanity itself might. What kinds of rights can be written into law to prevent this kind of extortion, that won’t also grant fetal personhood and end up derailing abortion rights? It’s going to be a bumpy ride, folks, buckle up!


A Chinese researcher claims he helped make the world’s first genetically edited babies — twin girls born this month, and with DNA he says he altered with a powerful new tool capable of rewriting the very blueprint of life.

If true, it would be a profound leap of science and ethics.

Continue reading “Many scientists denounce researcher claiming 1st gene-edited babies born in China” »

Nov 26, 2018

EXCLUSIVE: Chinese scientists are creating CRISPR babies

Posted by in categories: bioengineering, biotech/medical

A daring effort is under way to create the first children whose DNA has been tailored using gene editing.

Read more

Nov 26, 2018

AP Exclusive: First gene-edited babies claimed in China

Posted by in categories: bioengineering, biotech/medical, ethics, genetics

And so it begins…


HONG KONG (AP) — A Chinese researcher claims that he helped make the world’s first genetically edited babies — twin girls born this month whose DNA he said he altered with a powerful new tool capable of rewriting the very blueprint of life. If true, it would be a profound leap of science and ethics. A U.S. scientist said he took part in the work in China, but this kind of gene editing is banned in the United States because the DNA changes can pass to future generations and it risks harming other genes. Many mainstream scientists think it’s too unsafe to try, and some denounced the Chinese report as human experimentation.

Read more

Nov 25, 2018

Susceptible to Heart Disease? Gene Editing Could Change That

Posted by in categories: bioengineering, biotech/medical

Gene editing may be able to do what medications can’t.

Read more

Nov 25, 2018

Is it time to re-open the genetic modification debate?

Posted by in categories: bioengineering, genetics

The genetic engineering debate is heating up again, 15 years after mass protests curbed the use of the technology.

Read more

Nov 24, 2018

Next generation of biotech food heading for grocery stores

Posted by in categories: bioengineering, biotech/medical, food, genetics, sustainability

WASHINGTON (AP) — The next generation of biotech food is headed for the grocery aisles, and first up may be salad dressings or granola bars made with soybean oil genetically tweaked to be good for your heart.

By early next year, the first foods from plants or animals that had their DNA “edited” are expected to begin selling. It’s a different technology than today’s controversial “genetically modified” foods, more like faster breeding that promises to boost nutrition, spur crop growth, and make farm animals hardier and fruits and vegetables last longer.

The U.S. National Academy of Sciences has declared gene editing one of the breakthroughs needed to improve food production so the world can feed billions more people amid a changing climate. Yet governments are wrestling with how to regulate this powerful new tool. And after years of confusion and rancor, will shoppers accept gene-edited foods or view them as GMOs in disguise?

Continue reading “Next generation of biotech food heading for grocery stores” »

Nov 22, 2018

Bioengineered spinal discs show promise – in goats

Posted by in categories: bioengineering, life extension

As the shock-absorbing cartilage discs between our vertebrae degenerate due to aging, accidents or overuse, severe back pain can result. While some scientists have developed purely synthetic replacement discs, a recent test on goats indicates that bioengineered discs may be a better way to go.

Read more

Nov 22, 2018

Dual-Action Antibody Might Improve Immunotherapy Outcomes

Posted by in categories: bioengineering, biotech/medical

In a study published in the journal Immunology, Southampton University researchers have shown that a new antibody that they have engineered is able to combine two different anticancer approaches: depleting regulatory T cells and activating killer T cells [1].

Abstract

The costimulatory receptor 4-1BB is expressed on activated immune cells, including activated T cells. Antibodies targeting 4-1BB enhance the proliferation and survival of antigen-stimulated T cells in vitro and promote CD8 T cell-dependent anti-tumor immunity in pre-clinical cancer models. We found that T regulatory (Treg) cells infiltrating human or murine tumors expressed high amounts of 4-1BB. Intra-tumoral Treg cells were preferentially depleted by anti-4-1BB mAbs in vivo. Anti-4-1BB mAbs also promoted effector T cell agonism to promote tumor rejection. These distinct mechanisms were competitive and dependent on antibody isotype and FcgR availability. Administration of anti-4-1BB IgG2a, which preferentially depletes Treg cells, followed by either agonistic anti-4-1BB IgG1 or anti-PD-1 mAb augmented anti-tumor responses in multiple solid tumor models.

Continue reading “Dual-Action Antibody Might Improve Immunotherapy Outcomes” »